JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thoralf M. Sundt
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundt, T. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sundt, T. M.
Related Collections
Right arrow Anesthesia

J Thorac Cardiovasc Surg 2008;136:799
© 2008 The American Association for Thoracic Surgery

Letter to the Editor

Reply to the Editor:

Thoralf M. Sundt, MD

Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn

The first 20% of the full text of this article appears below.

I appreciate Dr Royston's kind comment regarding my editorial. I am quite certain that he agrees with me that we are "worse off without [aprotinin] in our arsenal." Indeed, I feel this sentiment particularly this evening, as I wait for a call from the operating room to start repair of an acute dissection in an 80-year-old patient who is receiving warfarin 5 years after coronary bypass and aortic valve replacement. I am also sure that he . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.